Albumin Market Report, Upcoming Trends and Opportunity Assessment by 2030
Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in...
0 Kommentare 0 Anteile 1KB Ansichten 0 Vorschau